Related Experiment Video
Updated: Aug 13, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Cloning and expression of human mitogen-activated protein kinase kinase 7gamma1
Laura Michael1, Jennifer Swantek, Megan J Robinson
1Pfizer Global Research & Development, Michigan Laboratories, Department of Inflammation Biology, Ann Arbor, USA. Laura.Michael@Pfizer.com
Abstract:
Mitogen-activated protein kinase kinase 7 (MKK7) is a direct activator of the mitogen-activated protein kinase family member c-Jun N-terminal kinase (JNK). MKK7 activates JNK via phosphorylation of a threonine and tyrosine residue in a Thr-Pro-Tyr motif within kinase subdomain VIII. To date at least six different isoforms of murine MKK7 have been identified. However, only three isoforms of human MKK7 have been reported. We report here the cloning of hMKK7gamma1, the human homolog of murine MKK7gamma1. Expression of hMKK7gamma1 mRNA was assessed and transcripts were present in low levels in placenta, fetal liver, and skeletal muscle. PCR results indicate that hMKK7gamma1 is expressed in various normal tissues, tumors, and in synoviocytes from rheumatoid and osteoarthritis patients. Recombinant hMKK7gamma1 can be phosphorylated and activated by MEKK1. Further studies will provide insight into the role for hMKK7gamma1 versus other MKK7 isoforms.
Insights
Researchers cloned human MKK7gamma1, a key activator of c-Jun N-terminal kinase (JNK). This MKK7 isoform is expressed in various human tissues, tumors, and synoviocytes, suggesting a role in cellular signaling and disease.
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- Mitogen-activated protein kinase kinase 7 (MKK7) is a critical activator of c-Jun N-terminal kinase (JNK).
- MKK7 activates JNK through phosphorylation of specific residues within kinase subdomain VIII.
- While six murine MKK7 isoforms are known, only three human isoforms have been reported.
Purpose of the Study:
- To report the cloning of hMKK7gamma1, the human homolog of murine MKK7gamma1.
- To investigate the expression patterns of hMKK7gamma1 in various human tissues and disease states.
- To assess the activation potential of recombinant hMKK7gamma1.
Main Methods:
- Cloning of the human MKK7gamma1 gene.
- Messenger RNA (mRNA) expression analysis using PCR in various tissues, tumors, and synoviocytes.
- In vitro phosphorylation and activation assays using recombinant hMKK7gamma1 and MEKK1.
Main Results:
- The human MKK7gamma1 gene was successfully cloned.
- hMKK7gamma1 mRNA transcripts were detected in placenta, fetal liver, and skeletal muscle.
- Expression was also observed in diverse normal tissues, tumors, and synoviocytes from patients with rheumatoid and osteoarthritis.
Conclusions:
- hMKK7gamma1 is a newly identified human MKK7 isoform.
- Its expression in various tissues and disease-associated cells suggests a significant role in human physiology and pathology.
- Recombinant hMKK7gamma1 can be activated by MEKK1, providing a basis for further functional studies.
Related Concept Videos
MAPK Signaling Cascades
Mitogens and the Cell Cycle
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

